Category: Cannabis
-
Supreme (FIRE.T) preps for big shopping trip in Europe
On June 24, 2019 Supreme Cannabis (FIRE.T) announced the launch of Supreme Heights, an investment platform based in London, UK “focused on opportunities in the UK and Europe’s CBD health and wellness space.” Supreme Cannabis’ portfolio includes the kick-ass brand 7ACRES, plant genetics co. Cambium Plant Sciences, oil producer Medigrow Lesotho and a licensing deal…
-
Chemesis (CSI.C) can now grow & process hemp in the USA
If you’ve been a parent of a teenager, you’ve watched in amazement as the gangly youngster grows new limbs overnight. So it is with Chemesis International (CSI.C). “Little Puerto Rico?” asked Chris Parry rhetorically in Equity Guru’s 1st article, “Who cares?” The company – born a year ago – hit puberty while it was still…
-
Supreme Cannabis (FIRE.T) is ready to lead the extracts boom ahead of final Health Canada approvals
Supreme Cannabis (FIRE.T) is clearing the final hurdles with Health Canada to make marijuana extracts a reality north of the border, setting the stage for a major production boost in a sub-industry worth billions. In a Tuesday press release, Supreme said it was on track to meet Health Canada’s amended cannabis regulations for edibles, extracts…
-
Good Deals, Good People: Biome (BIO.C) and TransCanna (TCAN.C) update
There are two things investors like to see: good deals and good people. On June 17, 2019 Biome Grow (BIO.C)’s 100%-owned subsidiary, Highland Grow received conditional approval to begin retail sales of cannabis in Saskatchewan. That’s a good deal for Biome. Equity Guru’s Sam Bourgi states that, “University of Regina professor Jason Childs expects Saskatchewanians…
-
iAnthus (IAN.C) retools stock option plan: Pitchforks and torches lowered as shorts bail
Sunlight is the best disinfectant, or so the old saying goes, meaning it’s only when bad things are exposed that bad things are corrected. US multi-state dispensary operator iAnthus (IAN.C), it seems, is soaking up the rays today. Hadley Ford, chief executive officer of iAnthus, stated: “We have cancelled recent option grants to members of…
-
Chemesis (CSI.C) QuickStrip: the Puerto Rico opportunity
Chemesis International (CSI.C) announced today that they have started selling Rapid Dose Therapeutics’ (DOSE.C) QuickStrip oral thin strips across the United States and Puerto Rico. QuickStrips is a sublingual delivery system for THC, CBD and other compounds that sports a low onset time. You pop it under your tongue and it dissolves in seconds, like…
-
C21 Investments (CXXI.C): Now the clown car has emptied, C21 trades at 2.5x sales
Back in December, I wrote a few stories about C21 Investments (CXXI.C), and how, at a $50 million market cap and $0.71 share price, and with $35m in revenues coming in from US assets, it was a bit of a steal. Someone, somewhere, agreed, and the share price of CXXI went on a tear from…
-
MedMen (MMEN.C) execs get real fricken nasty (again)
If you owned a 5% share in a 300-foot yacht, and the captain refused to let you sell your interest – then ran the ship aground – you’d have an idea how early MedMen (MMEN.C) investors, Brent Cox and Omar Mangalji feel. Collectively, Cox and Mangalji own about 19 million shares of MedMen – a…
-
Pasha Brands (CRFT.C) buys Medcann, a Health Canada approved processor & cultivator.
Pasha Brands (CRFT.C) has only been public for 4 days. On April 30, 2019 – when it was still a private company – it signed a Letter of Intent (L.O.I) to acquire Medcann – a fully licensed, Health Canada approved facility “to process, cultivate and sell medical cannabis under the Cannabis Act regulations.” L.O.Is –…